Chemoembolization with or without an oral treatment drug (Sorafenib) for liver cancer that cannot be removed surgically.
Participants can have Cirrhosis and at least 1 lesion greater than 2 centimeters or an AFP greater than 400 and at least 1 lesion greater than 2 centimeters. Disease must be limited to the liver but must be less than 50% diseased. RFA is allowed if it was more than 4 weeks ago. Participants also include those who have Child-Pugh A or B7.
Exclusions include, but are not limited to: Detectable ascites on physical exam or main portal vein invasion.
“You had such excellent speakers here that what they did for me was made me less afraid... so that if anything happened to me, I would know the processes to go through and what to ask for to benefit me as a person.”